Related Experiment Video

Updated: Aug 20, 2026

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
15:43

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 17, 2014

Applying lessons learned in the treatment of diffuse panbronchiolitis to other chronic inflammatory diseases

Shoji Kudoh1

  • 1Nippon Medical School, Tokyo, Japan.

The American Journal of Medicine
|December 14, 2004
PubMed

Insights

Macrolides, known for antibacterial and anti-inflammatory effects, significantly improve survival in diffuse panbronchiolitis (DPB). Their mechanisms in treating chronic airway inflammation are under investigation for other diseases.

Area of Science:

  • Pulmonology
  • Pharmacology
  • Immunology

Background:

  • Macrolides possess both antibacterial and anti-inflammatory properties.
  • Diffuse panbronchiolitis (DPB) is a chronic airway inflammatory disease with high mortality.
  • Long-term macrolide therapy has proven effective in improving survival for DPB patients.

Purpose of the Study:

  • To explore the anti-inflammatory mechanisms of macrolides.
  • To investigate the potential of macrolides in treating other chronic inflammatory airway diseases.

Main Methods:

  • Review of existing literature on macrolide mechanisms and clinical applications.
  • Analysis of macrolide effects on neutrophil chemotaxis, adhesion molecule expression, and cytokine formation.
  • Examination of macrolide impact on mucus secretion.

Main Results:

  • Macrolides reduce neutrophil migration and infiltration into the respiratory tract.
  • They inhibit pro-inflammatory cytokine production and transcription factor expression.
  • Macrolides effectively decrease mucus secretion through direct and indirect pathways.

Conclusions:

  • Macrolides demonstrate significant anti-inflammatory effects relevant to chronic airway diseases.
  • Their safety and tolerability support long-term use.
  • Similarities between DPB, cystic fibrosis, and chronic bronchitis suggest macrolides' potential therapeutic value in these conditions.

Related Concept Videos

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...